2004
DOI: 10.1124/jpet.103.063289
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of Recombinant Human Leukemia Inhibitory Factor in Sheep

Abstract: The pharmacokinetics of recombinant human leukemia inhibitory factor (rhLIF) were investigated following i.v. and s.c. administration of a wide range of dose levels. Parallel studies were conducted where single i.v. bolus doses of 12.5, 25, 100, 250, 500, or 750 g/kg rhLIF (n ϭ 2) or s.c. doses of 10, 20, or 50 g/kg rhLIF (n ϭ 4) were administered to sheep. Blood samples were collected for up to 24 h postdosing, and the plasma concentrations of rhLIF were analyzed by enzyme-linked immunosorbent assay. Noncompa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 36 publications
(34 reference statements)
0
21
0
Order By: Relevance
“…4 The quasi-equilibrium model (QEM) was applied to leukemia inhibitory factor (LIF) pharmacokinetic data in sheep; these data had been characterized previously using the TMDD model. 5 Predicted concentration-time profi les appeared to be identical in the 2 models, and there was good agreement in parameter estimates, with the exception of the K D term. Although several explanations might exist, it was hypothesized that the model may be insensitive to K D values.…”
Section: Partial Derivative -Based Sensitivity Analysis Of Models Desmentioning
confidence: 88%
See 1 more Smart Citation
“…4 The quasi-equilibrium model (QEM) was applied to leukemia inhibitory factor (LIF) pharmacokinetic data in sheep; these data had been characterized previously using the TMDD model. 5 Predicted concentration-time profi les appeared to be identical in the 2 models, and there was good agreement in parameter estimates, with the exception of the K D term. Although several explanations might exist, it was hypothesized that the model may be insensitive to K D values.…”
Section: Partial Derivative -Based Sensitivity Analysis Of Models Desmentioning
confidence: 88%
“…12 A series of simulations were conducted with differing parameter values, which were varied 10-, 100-, and 1000-fold on the lower and higher side of the LIF base value. 5 Each simulation was conducted by altering 1 parameter at a time and fi xing all remaining parameter values. All simulations were performed using WinNonlin.…”
Section: Sensitivity Analysismentioning
confidence: 99%
“…Recently, several versions using approximation have been proposed (9)(10)(11), including the rapidbinding approximation of TMDD model (RB-TMDD), which replaces the inestimable binding micro-constants (k on and k off ) with an equilibrium dissociation constant (K D ). The RB-TMDD model has been applied to some preclinical and clinical studies where the target is membrane-bound receptor (12) or the binding takes place interstitially (13), but its application to circulating soluble targets just started to emerge (14). In fact, the latter case may be better depicted by this model because the encounter of a drug with a target in the circulation would negate distribution of the drug to a binding site outside the vasculature.…”
Section: Introductionmentioning
confidence: 97%
“…A general PK model of TMDD has been described (5) and has since been utilized to characterize the PK of several compounds in humans and animals, including: bosentan and imirestat (5), interferon-b1a (6,7), vascular endothelial growth factor (8), warfarin (9), thrombopoietin (10), and leukemia inhibitory factor (LIF) (11). This modeling approach essentially integrates the thermodynamics of drugtarget binding within the system of ordinary differential equations that describe drug disposition (see Theoretical), and drug-binding microconstants (k on and k off ) are included in the model.…”
Section: Introductionmentioning
confidence: 99%